References
- Brunzell J D, Alters J J, Haas L B, Goldberg A P, Agadon L, Sherrard D J. Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 1977; 26: 903–10
- Ponticelli C, Barbi G, Cataluppi A, Donati C, Annoni G, Brancacci D. Lipid abnormalities in maintenance dialysis patients and renal transplant recipients. Kidney Int 1978; 13: 572–8
- Bagdade J D, Albers J J. Plasma high-density lipoprotein concentrations in chronic hemodialysis and renal transplant patients. N Engl J Med 1977; 296: 1436–9
- Rapoport J, Aviram M, Chaimovitz C, Brook J G. Defective high-density lipoprotein composition in patients on chronic hemodialysis. N Engl J Med 1978; 299: 1326–9
- Cassader M, Ruiu G, Tagliaferro V, Triolo G, Pagano G. Lipoprotein and apoprotein levels in different types of dialysis. Int J Artif Organs 1989; 12: 433–8
- Nestel P J, Fidge N H, Tan M H. Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 1982; 307: 329–33
- Norbeck H E, Carlsson L A. Increased frequency of late pre-β lipoproteins in isolated serum very low density lipoproteins in uraemia. Eur J Clin Invest 1980; 10: 423–6
- Chan M K, Persaud J, Varghese Z, Moorhead J F. Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 1984; 25: 812–8
- Applebaum-Bowden D, Goldberg A P, Hazzard W R, et al. Post-heparin plasma triglyceride lipase in chronic haemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism. Metabolism 1979; 28: 919–24
- Crawford G A, Savdie E, Stewart J H. Heparin-released plasma lipases in chronic renal failure and after renal transplantation. Clin Sci 1979; 57: 155–65
- Murase T, Cattran D C, Rubenstein B, Steiner G. Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism 1975; 24: 1279–86
- Cryer A. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. Int J Biochem 1981; 13: 525–42
- Westervelt F B. Insulin effect in uremia. J Lab Clin Med 1969; 74: 79–84
- Goldberg A, Sherrard D J, Brunzell J D. Adipose tissue lipoprotein lipase in chronic hemodialysis: Role in plasma triglyceride metabolism. J Clin Endocrinol Metabol 1978; 47: 1173–82
- Persson B. Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature. Acta Med Scand 1973; 193: 457–62
- Chan M K, Varghese Z, Moorhead J F. Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 1981; 19: 625–37
- Persson E, Nordenstrom J, Nilsson-Ehle P. Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment. Scand J Clin Lab Invest 1987; 47: 151–5
- Liu G, Bengtsson-Olivecrona G, Ostergaard P, Olivecrona T. Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme. Biochem J 1991; 273: 747–52
- Teien A N, Lie M. Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III. Thromb Res 1977; 10: 399–410
- Schrader J, Stibbe W, Armstrong V W, et al. Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int 1988; 33: 890–6
- Danielsson B, Ekman R, Fex G, et al. Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest 1978; 38: 113–19
- Nilsson-Ehle P, Ekman R. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 1977; 3: 194–209
- Akiba T, Tachibana K, Ozawa K, et al. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis. ASAIO 1992; 38: M326–M330
- Deuber H J, Schulz W. Reduced lipid concentrations during four years of dialysis with low molecular weight heparin. Kidney Int 1991; 40: 496–500
- Schmitt Y, Schneider H. Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis. Nephrol Dial Transplant 1993; 8: 438–42
- Bagdade J D, Porte D, Bierman E L. Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med 1968; 279: 181–5
- Ibels L S, Reardon M F, Nestel P H. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients. J Lab Clin Med 1976; 87: 648–58
- Tsaltas T T, Friedman E A. Plasma lipid studies of uremic patients during hemodialysis. Am J Clin Nutr 1968; 21: 430–5